GV20 Therapeutics is the US branch of GV20 Oncotherapy. The company utilizes high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. GV20's proprietary antibody drug discovery engine has helped establish a solid portfolio of immuno-oncology antibody drug candidates for cancer treatment.

Pharmaceutical

GV20 Therapeutics

Shirley Liu

Flavian D. Brown

Xihao Hu

Xingfeng Bao

Jie Chen

Karim Benhadji

Sherlock Hu

Ying Gong

Ted Xiao

Leadership Team

Research and Development

Information Technology

Marketing and Communications

Teams at GV20 Therapeutics

Leadership Team

Research and Development

Information Technology

Marketing and Communications